ivan health semaglutide Canada's market authorisation for our generic Injection makes us the first company to receive this authorisation in Canada. This milestone reflects our deep focus on complex generics and peptide based Semaglutide for Weight Loss |

Please try a different keyword

A sane rate of loss

Reported Issues: Consumers report: That this product did not lead to weight loss or appetite suppression as advertised That this product was marketed using misleading claims about GLP-1 support That they paid for a product that did not provide the promised benefits That the supplements were promoted as alternatives to GLP-1 medications, despite not functioning like prescription GLP-1 drugs That marketing materials imply that these supplements are scientifically and medically proven and reliable, when evidence may be lacking That they would not have purchased the supplements if they had known the claims were not supported by reliable scientific evidence Why Individuals Should Be Concerned: Potential claims include: Economic loss False advertising Product defect Performance vs

BTH gave me sound advice and helped me to formulate a personalized plan that worked for me!"